Загрузка...
Efficacy of Switching From Teriparatide to Bisphosphonate or Denosumab: A Prospective, Randomized, Open‐Label Trial
There is no consensus on an optimal treatment after daily teriparatide (TPTD). We performed a prospective, randomized, open‐label, 12‐month trial to investigate the efficacy of follow‐up treatment after daily TPTD treatment for Japanese patients. Three‐hundred patients were enrolled in this study. P...
Сохранить в:
| Опубликовано в: : | JBMR Plus |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6139701/ https://ncbi.nlm.nih.gov/pubmed/30283910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10054 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|